Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Type I interferons play a key role in the development of various skin diseases.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ruxolitinib treatment may cause eyelash growth.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The research found that the gene activity in mouse skin stem cells changes significantly as they age.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Dermal papilla cells are key for hair growth and color, influencing hair type and size, and their interaction with stem cells could help treat hair loss and color disorders.

Gray hair can potentially be reversed, leading to new treatments.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

The Asiatic lion has very low genetic diversity and unique genetic traits, highlighting the need for its conservation.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.